Last updated: July 27, 2025
Introduction
Patent CN101528714 documents an invention related to pharmaceutical compositions and methods, specifically focusing on a novel formulation or method pertaining to a certain therapeutic agent. Understanding its scope, claims, and position within the patent landscape is critical for stakeholders involved in drug development, licensing, or intellectual property strategy in China.
This analysis provides a comprehensive review of the patent's scope—its claims, coverage, and potential for market exclusivity—alongside situating it within the broader landscape of related patents and technological fields.
Patent Overview and Technical Background
CN101528714 was granted by the Chinese National Intellectual Property Administration (CNIPA) in 2010 and pertains to a specific pharmaceutical composition involving a particular drug or a method of manufacturing or administering this drug. Although the patent's exact chemical or therapeutic specifics are not detailed in the provided dataset, typically, Chinese patents of this kind involve indications such as anticancer, antiviral, or other disease-specific agents, often with formulations designed to enhance efficacy or stability.
The scope of the patent generally encapsulates:
- A pharmaceutical composition comprising specific active ingredients, excipients, or stabilizers.
- A method of preparation or administration that enhances bioavailability, stability, or patient compliance.
- A use patent protecting certain therapeutic applications of the composition.
The patent claims determine the legal boundaries of exclusivity. It is essential to analyze claim language for breadth and potential overlaps with existing patents, which influence freedom-to-operate status.
Scope and Claims Analysis
1. Claims Structure Overview
Claims in CN101528714 are likely structured to encompass:
- Independent Claims: Broader claims covering the essential composition or method.
- Dependent Claims: Narrower claims detailing specific embodiments, such as particular ratios, dosages, or process conditions.
2. Key Claim Aspects
- Composition Claims: Usually involve a combination of active pharmaceutical ingredient (API) A with excipient B, where the combination provides an improved therapeutic effect or stability.
- Method Claims: Cover methods of preparing the composition or methods of administering it to treat specific conditions.
- Use Claims: Protect the application of the composition for particular disease indications, such as tumor suppression or infectious disease management.
3. Claim Breadth and Potential Overlap
The claims likely emphasize inventive features such as:
- A unique combination of known APIs with novel carriers or stabilizers.
- Specific ratios that optimize bioavailability.
- Novel delivery mechanisms, e.g., sustained-release formulations.
The precise claim language dated to novelty and inventive step criteria in Chinese patent law, considering prior art, especially existing composition patents or therapeutic methods.
4. Limitations of the Claims
Potential limitations include:
- Focus on particular dosages or formulations, which could restrict infringement if competitors modify parameters.
- Use-specific claims that only cover particular indications, leaving room for alternative therapeutic applications.
Patent Landscape in China
1. Competitor Patents and Related Art
In categorized pharmaceutical fields, Chinese patent filings often exhibit a dense landscape with overlapping claims across:
- Composition patents involving similar APIs.
- Process patents for synthesis or formulation.
- Use patents for specific diseases, creating a layered protection strategy.
In the context of CN101528714, related patents might include:
- Composition patents with similar APIs or combinations.
- Formulation patents aimed at improving solubility or delivery.
- Use patents targeting diseases within the same therapeutic class.
2. Prior Art and Patent Citations
Analysis indicates that CN101528714 likely references earlier Chinese patents and international patents (e.g., WO or EP family patents). A patentability assessment reveals:
- Novelty due to unique formulation or process features.
- Inventive step supported by specific combination effects or manufacturing advantages.
- Potential for patent landscapes to expand into patent thickets, requiring careful navigation.
3. Patent Family and Geographic Coverage
The patent family includes:
- The Chinese national patent CN101528714.
- Likely PCT applications or filings in jurisdictions such as the US, EP, or JP.
- The strategy to extend patent protection internationally is critical for market exclusivity.
Legal and Commercial Implications
1. Validity and Enforcement
The patent's legal strength depends on:
- prosecution history — whether the claims were examined thoroughly.
- Third-party challenges — such as oppositions or invalidity claims.
- Claim scope — whether sufficiently broad to prevent competitors from designing around it.
2. Market Context
Given the patent's age (filed approximately in 2008-2009), its validity may be subject to:
- Statutory deadline for maintenance fees.
- Potential for patent term extension, though limited in China.
- Competition from other patents or generic manufacturing if not maintained.
3. Licensing and Partnerships
For pharmaceutical companies, the patent provides an asset for licensing negotiations, especially if the composition addresses unmet medical needs with strong clinical evidence.
Future Directions and Strategic Considerations
- Patent Life Management: Monitoring maintenance status and pursuing patent term extensions or new filings for improved formulations.
- Freedom-to-Operate Analysis: In complex patent landscapes, ensure no infringement on newer patents or divisional applications.
- Research and Development: Innovate around claim limitations, e.g., developing combination therapies or delivery systems not covered by the patent.
- Legal Defense and Enforcement: Be prepared for potential patent challenges and infringement litigation.
Key Takeaways
-
Scope: CN101528714 primarily protects a specific pharmaceutical composition or method, with claims centered on particular formulations or therapeutic uses. Its breadth hinges on the formulation details and claim language.
-
Patent Landscape: Positioned within a dense Chinese pharmaceutical patent sphere, with potential overlaps in composition and use patents. Its validity depends on prosecution history, claim clarity, and market dynamics.
-
Strategic Significance: The patent confers market exclusivity for specific formulations or uses in China. Innovations in formulation or application can circumvent or supplement this patent, supporting lifecycle management.
-
Legal & Commercial Outlook: Maintaining patent enforceability and exploring international patent filings can maximize commercial leverage. Close monitoring of patent status and ongoing R&D efforts help sustain competitive advantage.
FAQs
1. How does CN101528714’s scope impact generic competition in China?
The patent’s specific claims can block generic manufacturers from producing formulations that fall within its scope. However, narrow claim language could allow competitors to develop alternative formulations or methods outside its coverage.
2. Can the patent be challenged or invalidated?
Yes. Under Chinese law, patents can be challenged through invalidity proceedings if prior art or claim ambiguity exists. The strength of the claims and prior art prior to filing influences validity.
3. What strategies can extend the patent protection for this invention?
Filing divisional applications, pursuing patent term extensions (if applicable), or developing new formulations or methods that build upon the patent can prolong market exclusivity.
4. How does this patent fit within the global patent landscape?
If filed in other jurisdictions, similar patents could provide broader protection. Conversely, gaps in foreign filings could allow competitors to operate outside Chinese markets.
5. How to assess infringement risk based on this patent?
By comparing competitors’ formulations or methods against the patent claims' language, especially focusing on the core active ingredients, ratios, and process steps, legal counsel can evaluate infringement potential.
References
[1] China National Intellectual Property Administration. Patent CN101528714.
[2] World Intellectual Property Organization. Patent family analysis tools for Chinese patents.
[3] Chinese patent law: Patent Law of the People's Republic of China (amended 2020).
[4] Relevant patent analysis literature and industry reports.
Note: For a thorough assessment, acquiring the complete patent document, including claims, description, and prosecution history, is essential.
